Status:
UNKNOWN
Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Borderlone Personality Disorder
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Personality disorders are life-long maladaptive behavioral patterns. Borderline personality disorder (BPD) is the leading personality disorder encountered in clinical settings, often associated with t...
Eligibility Criteria
Inclusion
- Women with Borderline PD according to DSM-IV
- Signed informed consent.
- Age 18-45.
Exclusion
- Psychotic disorders (past or present).
- Substance or alcohol related disorders (past or present).
- Current major depressive episode.
- Suicidal risk.
- History of head trauma, which caused loss of consciousness or peritraumatic amnesia or necessitated hospitalization.
- Any known psychiatric or general medical condition currently requiring specific medical attention.
- Current treatment with any antipsychotic, antidepressant drugs or mood stabilizers.
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00633802
Start Date
April 1 2004
Last Update
March 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Service, Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel